Novel Drug Authorized for Critically Ill COVID-19 Patients
The FDA has issued an emergency use authorization (EUA) for vilobelimab (Gohibic) to treat critically ill adults with COVID-19. In the EUA for the first-in-class monoclonal anti-human complement factor C5a antibody, the agency specified that the therapy be initiated within 48 hours of invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO). It is given at […]
Novel Siderophore Cephalosporin Nets Promising Results in Tough-to-Treat CRAB
WASHINGTON – Cefiderocol (Fetroja) may be a viable targeted-therapy option in critically ill patients with carbapenem-resistant Acinetobacter baumannii infections (CRAB), according to the ongoing PROVE trial. In the real-world setting, patients with CRAB often had multiple comorbidities, including severe burns, which complicates therapy, explained Stephen Marcella, MD, of Shionogi in Florham Park, New Jersey. He […]
Warming Atlantic drives right whales towards extinction
Warming oceans have driven the critically endangered North Atlantic right whale population from its traditional and protected habitat, exposing the animals to more lethal ship strikes, disastrous commercial fishing entanglements and greatly reduced calving rates. Without improving its management, the right whale populations will decline and potentially become extinct in the coming decades, according to […]